Evidence map›Paper›PMID 22848540›Full record

ArticlePloS one2012

LRP5 regulates development of lung microvessels and alveoli through the angiopoietin-Tie2 pathway.

Tadanori Mammoto, Jing Chen, Elisabeth Jiang, Amanda Jiang, Lois E Smith, Donald E Ingber, Akiko Mammoto

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
1.5field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 38 citations in OpenAlex.

  1. Angiogenesis in Lung Regeneration and Aging.Arteriosclerosis, thrombosis, and vascular biology · 2026
    Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Endothelial deletion ofbioRxiv : the preprint server for biology · 2024
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Endothelial YAP1 in Regenerative Lung Growth through the Angiopoietin-Tie2 Pathway.American journal of respiratory cell and molecular biology · 2019
    Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Tadanori MammotoVascular Biology Program, Department of Surgery, Boston Children's Hospital and Harvard Medical School, Boston, Massachusetts, United States of America.
Jing Chen
Elisabeth Jiang
Amanda Jiang
Lois E Smith
Donald E Ingber
Akiko Mammoto
Harvard University · USBoston Children's Hospital · USDana-Farber/Boston Children's Cancer and Blood Disorders Center · US

Funding

SYNAPTIC MECHANISMS IN HIPPOCAMPAL EPILEPTOGENESISP30HD018655 · NICHD · CHILDREN'S HOSPITAL BOSTON · PI POMEROY, SCOTT LOREN · 1985 to 2015
$26.2M
TUMOR DORMANCY INDUCED BY BLOCKED ANGIOGENESISP01CA045548 · NCI · CHILDREN'S HOSPITAL BOSTON · PI KLAGSBRUN, MICHAEL · 1987 to 2011
$22.6M
Dietary control of angiogenesis in retinopathy modelsR01EY017017 · NEI · BOSTON CHILDREN'S HOSPITAL · PI Zhongjie Fu, Lois Smith · 2006 to 2026
$11.8M
Micromechanical Determinants of Organ Design and Engineering (SysCODE 6 of 10)RL1DE019023 · NIDCR · BOSTON CHILDREN'S HOSPITAL · PI INGBER, DONALD E · 2007 to 2011
$2.9M
Neuronal guidance molecules control revascularization in retinopathyR01EY022275 · NEI · BOSTON CHILDREN'S HOSPITAL · PI SMITH, LOIS · 2012 to 2014
$1.3M
NCI NIH HHS CA45548NCI NIH HHS P01 CA045548NEI NIH HHS EY017017NEI NIH HHS EY022275NEI NIH HHS R01 EY017017NEI NIH HHS R01 EY022275NICHD NIH HHS P01 HD18655NICHD NIH HHS P30 HD018655NIDCR NIH HHS DE019023NIDCR NIH HHS RL1 DE019023
6 · The paper itself

Abstract

Angiogenesis is crucial for lung development. Although there has been considerable exploration, the mechanism by which lung vascular and alveolar formation is controlled is still not completely understood. Here we show that low-density lipoprotein receptor-related protein 5 (LRP5), a component of the Wnt ligand-receptor complex, regulates angiogenesis and alveolar formation in the lung by modulating expression of the angiopoietin (Ang) receptor, Tie2, in vascular endothelial cells (ECs). Vascular development in whole mouse lungs and in cultured ECs is controlled by LRP5 signaling, which is, in turn, governed by a balance between the activities of the antagonistic Tie2 ligands, Ang1 and Ang2. Under physiological conditions when Ang1 is dominant, LRP5 knockdown decreases Tie2 expression and thereby, inhibits vascular and alveolar development in the lung. Conversely, when Ang2 dominates under hyperoxia treatment in neonatal mice, high LRP5 and Tie2 expression suppress angiogenesis and lung development. These findings suggest that the LRP5-Tie2-Ang signaling axis plays a central role in control of both angiogenesis and alveolarization during postnatal lung development, and that deregulation of this signaling mechanism might lead to developmental abnormalities of the lung, such as are observed in bronchopulmonary dysplasia (BPD).

Indexed as

Signal TransductionAngiopoietin-1Angiopoietin-2AnimalsCell HypoxiaEndothelial CellsGene Expression RegulationHumansLow Density Lipoprotein Receptor-Related Protein-5MiceMice, Inbred C57BLMicrovesselsPulmonary AlveoliReceptor Protein-Tyrosine KinasesReceptor, TIE-2Angiopoietin-1Angiopoietin-2Low Density Lipoprotein Receptor-Related Protein-5Lrp5 protein, mouseReceptor Protein-Tyrosine KinasesReceptor, TIE-2Tek protein, mouse

Identifiers

PMID22848540
PMCPMC3404972
OpenAlexW2166337452

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.